Page results
-
How we use your information at UCLH: what you need to know.
-
Macmillan Support and Information Service offer emotional support, advice and information to people affected by cancer and blood conditions.
-
This booklet is designed for teenagers and young people. It explains what you can expect when you finish your treatment for Hodgkin lymphoma.
-
All HPB and hepatology clinical and academic services, including pancreatic cancer services, have transferred from UCLH to the Royal Free Hampstead NHS Trust, creating one of the largest centres in Europe for the treatment of conditions of the liver, pancreas and biliary system.
-
This service is unique in the UK, offering an adolescent rheumatology service that provides diagnostic and therapeutic advice to patients with any rheumatic diseases that occur in adolescence.
-
Information on safer eating during treatment, for patients with blood cancer.
-
The pancreatobiliary department at UCLH is one of few centres in the UK to provide a patient-centred, comprehensive advanced interventional endoscopy service for diseases of the pancreas and biliary tree.
-
Our thoracic/respiratory medicine service offers a comprehensive inpatient and outpatient medical service for adults with conditions affecting the lungs.
-
Postnatal care should be a continuation of the care the woman has received through her pregnancy, labour and birth and take into account the woman’s individual needs and preferences.
-
Health and wellbeing information for people affected by cancer.
File results
-
FOI/2023/0386 - Sickle Cell staffing and patients
-
FOI/2023/0384 - Cyber security attacks 2020-2022
-
FOI/2023/0383 - Cataract referrals
-
FOI/2023/0380 - Flexible nurse bank rates/ spend March 2023
-
FOI/2023/0379 - MDT meetings in relation to tailgut cysts
-
FOI/2023/0376 - Director of Estate and Facilities/ Head of Patient Experience contact details
-
FOI/2023/0082 - Organisation structure for Performance and Planning department
-
FOI/2023/0081 - Biometric technology wearables/ data collection
-
FOI/2023/0080 - Treatment for Myeloid leukaemia (AML) and chronic lymphocytic leukaemia
-
FOI/2023/0083 - Software systems/ suppliers used at Trust